Abstract:This study focuses on the synthesis of novel 2,3‐disubstituted quinazolin‐4(3H)‐one derivatives and evaluates their antibacterial properties against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Bacillus cereus. The antibacterial activity GA4A1 exhibited notable efficacy against E. coli, which was further supported by the highest molecular docking score and stable binding interactions in molecular dynamics simulations. The findings highlight that Compound GA4A1 is a promising candidate for further development as an antimicrobial agent against E. coli. The rise of multidrug‐resistant organisms (MDROs) represents a significant challenge to healthcare, underscoring the need for novel antimicrobial agents. Quinazolinone compounds, noted for their diverse biological activities, particularly at the 2nd and 3rd positions, in conjunction with sulphanilamide and isatin derivatives, present a promising avenue for antibacterial development. This study focuses on the synthesis of novel 2,3‐disubstituted quinazolin‐4(3H)‐one derivatives from Schiff base intermediates GA3A and GA3B. The synthesis involved the reaction of 2‐(substituted phenyl)‐4H‐benzo[d][1,3]‐oxazin‐4‐one with sulphanilamide, and the benzoxazinone intermediates were prepared by reacting anthranilic acid with benzoyl chloride. The antibacterial activities of the Schiff base intermediates and the final Mannich base compounds were evaluated against Staphylococcus aureus, Bacillus cereus, Escherichia coli, and Pseudomonas aeruginosa at concentrations of 50 μg/mL and 100 μg/mL using the agar well diffusion method, with Norfloxacin (50 μg/mL) as the reference standard. While all tested compounds exhibited lower antibacterial activity compared to the standard, GA4A1 showed enhanced efficacy against E. coli, achieving the highest docking score of 78.0352 against the E. coli protein (PDB ID: 1KZN). Molecular dynamics simulations revealed that the GA4A1‐E. coli complex stabilized after 40,000 ps, with root mean square deviation (RMSD) values ranging from 2.5 Å to 5 Å and low root mean square fluctuation (RMSF) values between 0.05 Å and 0.2 Å, indicating the stability of the complex. These findings underscore GA4A1's potential as a potent antimicrobial agent against E. coli.

Quinazolinone azolyl ethanols: potential lead antimicrobial agents with dual action modes targeting MRSA DNA

Multi-Targeting Exploration of New 2-Aminothiazolyl Quinolones: Synthesis, Antimicrobial Evaluation, Interaction with Dna, Combination with Topoisomerase Iv and Penetrability into Cells

Design, synthesis, and biological evaluation of novel carbazole aminothiazoles as potential DNA-targeting antimicrobial agents

Design, synthesis, and antibacterial evaluation of novel azolylthioether quinolones as MRSA DNA intercalators

Discovery of Benzimidazole–Quinolone Hybrids As New Cleaving Agents Toward Drug‐Resistant Pseudomonas Aeruginosa DNA

Design, Synthesis, and Antimicrobial Evaluation of Novel Quinolone Imidazoles and Interactions with MRSA DNA

Unique Aminothiazolyl Coumarins As Potential DNA and Membrane Disruptors Towards Enterococcus Faecalis

Novel Aminopyrimidinyl Benzimidazoles As Potentially Antimicrobial Agents: Design, Synthesis and Biological Evaluation

Novel Thiazolylketenyl Quinazolinones as Potential Anti-MRSA Agents and Allosteric Modulator for PBP2a

Novel quinoline/thiazinan-4-one hybrids; design, synthesis, and molecular docking studies as potential anti-bacterial candidates against MRSA

Potential antibacterial ethanol-bridged purine azole hybrids as dual-targeting inhibitors of MRSA

2,3-bis (phenylamino) quinoxaline - containing compounds display potent activity against Methicillin-resistant , and their biofilms

Synthesis and antibacterial medicinal evaluation of carbothioamido hydrazonyl thiazolylquinolone with multitargeting antimicrobial potential to combat increasingly global resistance

Identification of CH2-linked Quinolone-Aminopyrimidine Hybrids As Potent Anti-Mrsa Agents: Low Resistance Potential and Lack of Cross-Resistance with Fluoroquinolone Antibiotics

Unique para-aminobenzenesulfonyl oxadiazoles as novel structural potential membrane active antibacterial agents towards drug-resistant methicillin resistant Staphylococcus aureus

Novel Benzothiazole‒urea Hybrids: Design, Synthesis and Biological Activity As Potent Anti-Bacterial Agents Against MRSA.

Design and Biological Evaluation of Novel Quinolone-Based Metronidazole Derivatives As Potent Cu(2+) Mediated DNA-targeting Antibacterial Agents.

Design and Synthesis of Novel Desfluoroquinolone-Aminopyrimidine Hybrids As Potent Anti-Mrsa Agents with Low Herg Activity

New Efforts Toward Aminothiazolylquinolones with Multitargeting Antibacterial Potential

Quinoline-based Anti-Mrsa Agents: Current Development, Structure-Activity Relationships, and Mechanisms

Synthesis, Antimicrobial Evaluation, Molecular Docking and Dynamics Simulations of Novel 2,3‐Disubstituted Quinazolin‐4(3H)‐one Derivatives